Estee Lauder Is Revising Claims, Retesting Products After Internal Breakdown
This article was originally published in The Rose Sheet
Executive Summary
Lauder says “a small group of employees” is responsible for intentionally altering testing behind product claims, misconduct alerted to management through the firm’s internal escalation process. Currently, the scope of the issue – and the potential impact on Lauder’s business – is unclear, but claims revisions of varying magnitude are expected as the company’s review progresses.
You may also be interested in...
Lauder Upbeat About Clinique, While Namesake Shows ‘Big Brands Can Grow Fast’
Driven by Estee Lauder and Clinique, the firm achieved gains in North America in fiscal 2018, despite continued brick-and-mortar retail erosion, while capitalizing on China’s growing appetite for luxury beauty. In a call with analysts, CEO Freda provided a succinct update on the company’s review of potentially flawed product claims, an issue raised last quarter that now is expected not to be material.
Lauder Rides Asia, Skin-Care Momentum In Q3; Sales Up 18%
Firm’s skin-care business rose 31% in the third quarter, taking considerable weight off makeup, which faces leveling demand after the boom in recent years. With its “digital-first mindset,” Lauder plans to increase promotional investments substantially in the fourth quarter to hit the ground running in fiscal 2019.
Lauder Rides Asia, Skin-Care Momentum In Q3; Sales Up 18%
Firm’s skin-care business rose 31% in the third quarter, taking considerable weight off makeup, which faces leveling demand after the boom in recent years. With its “digital-first mindset,” Lauder plans to increase promotional investments substantially in the fourth quarter to hit the ground running in fiscal 2019.